Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan

 Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and
                                   Allergan

PR Newswire

LONDON, March 28, 2013

LONDON, March 28, 2013 /PRNewswire/ --

Markets failed to sustain its Tuesday gains and closed flat. Ongoing Cyprus
crisis had negative impact on the stocks as concerns about bank deposits grew
further. However, decline in prices was taken as a buying opportunity by the
markets and the indices closed flat. Our research team took a look at
Healthcare sector including major companies like Bristol Myers Squibb Co.
(NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Endo Health Solutions Inc. (NASDAQ:
ENDP) and Allergan Inc. (NYSE: AGN). StockCall professionals have completed
their technical analysis on BMY, LLY, ENDP, and AGN and these free reports are
accessible by registering at

http://www.stockcall.com/research 

Bristol Myers Squibb Co.'s stock closed at $40.78, 0.25 percent up. The stock
traded in the range of $40.36 and $40.83 during Wednesday's session, which is
also its 52 weeks high price point. It is currently trading above its 20-day
moving average price of $40.77. The company has gained 27.84 percent so far
this year. Its Price/Earnings ratio is 35.46, which makes it a slightly
expensive stock to own. It is in a bullish phase and its first resistance
level is at $40.95. On the downside, its first support is at $40.23. Upon
breaching this level, its second support level is at $39.85. Sign up for the
free technical research on BMY at

http://www.StockCall.com/BMY032813.pdf

With a mild gain in its previous trading session, Eli Lilly & Co. is still up
15.99 percent for the year. It has gained 41.83 percent in the past 52 weeks.
The stock closed 0.14 percent higher at $56.37 on volume of 3.42 shares
yesterday. Its average trading volume stands at 5.27 million shares. Eli Lilly
& Co.'s shares currently face resistance at around $56.55. Upon breaching this
level, it may go up to $56.85 level. The stock has support at around $56.04.
It is trading above its 20-day and 50-day moving average price of $55.22 and
$54.32, which is a bullish signal. Be sure to read our latest technical
research on LLY by registering at

http://www.StockCall.com/LLY032813.pdf

Endo Health Solutions Inc. traded in the range of $30.39 and $30.84 during
Wednesday's trading session. It opened at $30.55 and closed at $30.74, up 0.10
percent. The stock is currently in a bullish mode and has its first resistance
level at $30.85. Upon breaching this level, Endo Health Solutions may go as
high as $30.94. It traded 978,053 shares and is trading above its 20-day
moving average price of $30.68, confirming its bullish mode. Its first support
level is at $30.55. So far in year 2013, the stock is up 20.08 percent. Sign
up and read the complimentary report on ENDP at

http://www.StockCall.com/ENDP032813.pdf

In-line with the bearish sentiments shown by broad market indices, Allergan
Inc.'s stock finished 0.12 percent lower at $111.63, with volume down from
daily average of 1.30 million to 675,338 shares. The company's stock is up so
far in 2013 with its year-to-date gain at 23.85 percent. However, the stock
currently shows a neutral trend which is further confirmed by its MACD chart.
The company has its first support level at $111.05. In the coming trading
sessions, the stock is likely to go as high as $112.25. The free report on AGN
can be downloaded by signing up now at

http://www.StockCall.com/AGN032813.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at

http://www.stockcall.com 

SOURCE StockCall.com

Contact: Contact Person:William T. Knight, Email: info@stockcall.com, Contact
Number: +1(646)396-9857 (9:00 am EST - 01:30 pm EST)